Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Crispin T Hiley

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Lancet (London, England)|September 7, 2016
Challenges in molecular testing in non-small-cell lung cancer patients with advanced diseaseCrispin T Hiley, John Le Quesne, George Santis, et al.
Cancers|October 14, 2022
Dose-Response Analysis Describes Particularly Rapid Repopulation of Non-Small Cell Lung Cancer during Concurrent ChemoradiotherapyHuei-Tyng Huang, Michael G Nix, Douglas H Brand, et al.
International Journal of Radiation Oncology, Biology, Physics|December 26, 2006
Expression of vascular endothelial growth factor (VEGF) in locally invasive prostate cancer is prognostic for radiotherapy outcomeMelanie M L Green, Crispin T Hiley, Jonathan H Shanks, et al.
Oncology Research|March 9, 2026
Investigating the Immune Effects of Radiotherapy in Non-Small Cell Lung Cancer-Results of the PD-RAD StudyShuhui Cheng, Tiana Kordbacheh, Antonia Banyard, et al.
Cell|November 7, 2017
Allele-Specific HLA Loss and Immune Escape in Lung Cancer EvolutionNicholas McGranahan, Rachel Rosenthal, Crispin T Hiley, et al.
Nature|September 9, 2021
Using DNA sequencing data to quantify T cell fraction and therapy responseRobert Bentham, Kevin Litchfield, Thomas B K Watkins, et al.
Nature Communications|June 15, 2024
Deep cell phenotyping and spatial analysis of multiplexed imaging with TRACERx-PHLEXAlastair Magness, Emma Colliver, Katey S S Enfield, et al.
Nature|December 10, 2025
Somatic evolution following cancer treatment in normal tissueOriol Pich, Sophia Ward, Andrew Rowan, et al.
Nature Medicine|May 29, 2020
Geospatial immune variability illuminates differential evolution of lung adenocarcinomaKhalid AbdulJabbar, Shan E Ahmed Raza, Rachel Rosenthal, et al.
Clinical and Translational Radiation Oncology|October 19, 2020
CONCORDE: A phase I platform study of novel agents in combination with conventional radiotherapy in non-small-cell lung cancerGerard M Walls, Jamie B Oughton, Anthony J Chalmers, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Lancet (London, England)|September 7, 2016
Challenges in molecular testing in non-small-cell lung cancer patients with advanced diseaseCrispin T Hiley, John Le Quesne, George Santis, et al.
Cancers|October 14, 2022
Dose-Response Analysis Describes Particularly Rapid Repopulation of Non-Small Cell Lung Cancer during Concurrent ChemoradiotherapyHuei-Tyng Huang, Michael G Nix, Douglas H Brand, et al.
International Journal of Radiation Oncology, Biology, Physics|December 26, 2006
Expression of vascular endothelial growth factor (VEGF) in locally invasive prostate cancer is prognostic for radiotherapy outcomeMelanie M L Green, Crispin T Hiley, Jonathan H Shanks, et al.
Oncology Research|March 9, 2026
Investigating the Immune Effects of Radiotherapy in Non-Small Cell Lung Cancer-Results of the PD-RAD StudyShuhui Cheng, Tiana Kordbacheh, Antonia Banyard, et al.
Cell|November 7, 2017
Allele-Specific HLA Loss and Immune Escape in Lung Cancer EvolutionNicholas McGranahan, Rachel Rosenthal, Crispin T Hiley, et al.
Nature|September 9, 2021
Using DNA sequencing data to quantify T cell fraction and therapy responseRobert Bentham, Kevin Litchfield, Thomas B K Watkins, et al.
Nature Communications|June 15, 2024
Deep cell phenotyping and spatial analysis of multiplexed imaging with TRACERx-PHLEXAlastair Magness, Emma Colliver, Katey S S Enfield, et al.
Nature|December 10, 2025
Somatic evolution following cancer treatment in normal tissueOriol Pich, Sophia Ward, Andrew Rowan, et al.
Nature Medicine|May 29, 2020
Geospatial immune variability illuminates differential evolution of lung adenocarcinomaKhalid AbdulJabbar, Shan E Ahmed Raza, Rachel Rosenthal, et al.
Clinical and Translational Radiation Oncology|October 19, 2020
CONCORDE: A phase I platform study of novel agents in combination with conventional radiotherapy in non-small-cell lung cancerGerard M Walls, Jamie B Oughton, Anthony J Chalmers, et al.
Pageof 5